FiercePharmaOriginal article
{"a":[{"_":"Gastroenterologists flag clinical remission and its durability as unmet needs in IBD care: survey","$":{"href":"/marketing/gastroenterologists-spot-treatment-gaps-clinical-remission-rates-durability-among-ibd","hreflang":"en"}}]}
Neutral
AI Analysis
Summary
A survey of 36 U.S. gastroenterologists identified significant treatment gaps in the IBD drug market, with clinical remission and its durability flagged as unmet medical needs despite the expanding range of available therapies.
Importance:2/10
Sentiment:
0.00
IBDInflammatory Bowel DiseaseClinical RemissionTreatment GapsGastroenterologyMarket Analysis
Read the original article
Published by FiercePharma on July 24, 2026 8:58 AM